Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
GILD
#80
Gilead Sciences, Inc. - Common Stock
149.9
2
USD
+0.02%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+2.45%
Monthly Change
+14.35%
6 month change
+1.32%
Year Change
+33.59%
Previous Close
146.3
4
Open
149.9
2
Low
149.9
2
High
149.9
2
Volume
347
Markets
US Stock Market
Healthcare
Drug Manufacturers—General
GILD
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Documents
Quarterly
Annual
Value
Q1, 25
Q2, 25
Q3, 25
Q4, 25
Q1, 26
Q2, 26
TTM
Dividends per share
0.79
0.79
0.79
3.16
0.82
0.82
5.59
Dividend yield %
4.83
4.9
4.91
2.57
3.99
4.42
15.9
Payout ratio %
75.96
50.64
32.51
180.57
50.93
-9.7
254.31
News
Top Research Reports for Toyota Motor, CrowdStrike & Welltower
Can Bixlenvo Unlock New Growth for Gilead's HIV Business?
Gilead (GILD) Upgraded to Strong Buy: What Does It Mean for the Stock?
Wall Street Analysts See Gilead (GILD) as a Buy: Should You Invest?
Stock Market Today: Nasdaq Sinks As Crude Prices Climb; These Oil Names Break Out (Live Coverage)
Trump Admin To Target Biotechs With Curbs On Drug Pricing? What Investors Should Know
FDA Approves Gilead's New Single Tablet HIV Regimen - Gilead Sciences (NASDAQ:GILD)
Gilead Sciences Stock (GILD) Slips 2% Despite FDA Approval of Bixlenvo - TipRanks.com
Gilead Wins FDA Nod for Bixlenvo in Adults Living With HIV Infection
GSK Stock: Still One Of My Top Healthcare Picks (NYSE:GSK)
EC Approves Label Expansion of GILD's Trodelvy in First-line Metastatic TNBC
Making Drugs With AI: Biopharma Giants Gear Up For New Arena